Alan B. Lancz & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $975K | Hold |
8,790
| – | – | 0.98% | 25 |
|
|
2025
Q1 | $985K | Sell |
8,790
-500
| -5% | -$56K | 1.05% | 22 |
|
|
2024
Q4 | $858K | Sell |
9,290
-1,800
| -16% | -$166K | 0.87% | 25 |
|
|
2024
Q3 | $930K | Buy |
11,090
+500
| +5% | +$41.9K | 0.85% | 28 |
|
|
2024
Q2 | $727K | Buy |
+10,590
| New | +$727K | 0.72% | 32 |
|
|
2023
Q4 | $842K | Sell |
10,390
-300
| -3% | -$24.3K | 0.88% | 26 |
|
|
2023
Q3 | $801K | Sell |
10,690
-300
| -3% | -$22.5K | 0.91% | 25 |
|
|
2023
Q2 | $847K | Hold |
10,990
| – | – | 0.91% | 26 |
|
|
2023
Q1 | $912K | Hold |
10,990
| – | – | 0.95% | 22 |
|
|
2022
Q4 | $948K | Hold |
10,990
| – | – | 0.96% | 24 |
|
|
2022
Q3 | $678K | Hold |
10,990
| – | – | 0.8% | 31 |
|
|
2022
Q2 | $657K | Sell |
10,990
-100
| -0.9% | -$5.98K | 0.65% | 35 |
|
|
2022
Q1 | $659K | Hold |
11,090
| – | – | 0.58% | 43 |
|
|
2021
Q4 | $805K | Buy |
+11,090
| New | +$805K | 0.7% | 34 |
|